Papillary Thyroid Cancer Market Growth and Segments,2016-2026
Future Market Insights has announced the addition of the “Papillary Thyroid Cancer Market: Global Industry Analysis and Opportunity Assessment 2016-2026”report to their offering.
Future Market Insights has announced the addition of the “Papillary Thyroid Cancer Market: Global Industry Analysis and Opportunity Assessment 2016-2026”report to their offering.
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Global <strong>Papillary</strong><br />
<strong>Thyroid</strong> <strong>Cancer</strong><br />
<strong>Market</strong><br />
Share, Global Trends,<br />
Analysis, Research, Report,<br />
Opportunities,<br />
Segmentation <strong>and</strong> Forecast,<br />
<strong>2016</strong><br />
Future <strong>Market</strong> Insights<br />
www.futuremarketinsights.com<br />
sales@futuremarketinsights.com
Future <strong>Market</strong> Insights (FMI) is a premier provider of syndicated research reports, custom research reports, <strong>and</strong> consulting<br />
services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes,<br />
technology inputs, valuable growth insights, aerial view of the competitive framework, <strong>and</strong> future market trends.<br />
We provide research services at a global as well as regional level; key regions include GCC, ASEAN, <strong>and</strong> BRIC.<br />
Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Technology, Healthcare, <strong>and</strong><br />
Retail.<br />
We have a global presence with delivery centers across India specializing in providing global research reports <strong>and</strong> country<br />
research reports. FMI is headquartered out of London, U.K., with a state-of-the-art delivery center located in Pune, India.<br />
We combine our knowledge <strong>and</strong> learning from every corner of the world to distill it to one thing – the perfect solution for<br />
our client.<br />
Research Capabilities<br />
• Customized Research<br />
• Syndicated Research<br />
• Investment Research<br />
• Social Media Research<br />
Sector Coverage<br />
• Automotive <strong>and</strong> Transportation<br />
• Electronics, Semiconductor, <strong>and</strong> ICT<br />
• Retail <strong>and</strong> Consumer Products<br />
• Industrial Automation <strong>and</strong> Equipment<br />
• Chemicals & Materials<br />
• Food <strong>and</strong> Beverages<br />
• Services <strong>and</strong> Utilities<br />
• Energy, Mining, Oil, <strong>and</strong> Gas<br />
Customized<br />
Research<br />
Syndicated<br />
Research<br />
Investment<br />
Research<br />
Social Media<br />
Research<br />
Subscription Information<br />
For detailed subscription information please contact<br />
Hari. T (Sr. Manager - Global Business Development)<br />
T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268<br />
Email: hari.t@futuremarketinsights.com
Report Description<br />
<strong>Papillary</strong> thyroid cancer (PTC) also called papillary carcinoma is one of the most common<br />
type of thyroid cancer <strong>and</strong> it is most curable among other cancers. Follicular cancer,<br />
medullary cancer, <strong>and</strong> anaplastic cancer are other types of thyroid cancers. The<br />
prevalence rate of papillary thyroid cancer is 0.5-10 per 100,000 population. <strong>Papillary</strong><br />
thyroid carcinoma presents as asymptomatic thyroid nodules, increasing the size of<br />
nodule in patient is the primary symptom for this disease. Cough, dyspnea <strong>and</strong> dysphagia<br />
are the severe stage symptoms of papillary thyroid cancer <strong>and</strong> lump or swelling in the<br />
neck parts are the physical symptoms of the papillary thyroid cancer. Age, gender <strong>and</strong><br />
exposure to radiation affect the risk of papillary thyroid cancer. Itis more common in<br />
women than in men, <strong>and</strong> often occurs before age 45. People who have been exposed to<br />
large amounts of radiation, or who have had radiation therapy for medical problems in<br />
the head <strong>and</strong> neck have a more chance of getting thyroid cancer.<br />
To treat papillary thyroid cancer various methods are available which include surgical<br />
procedure, iodine therapy, thyroxin treatment <strong>and</strong> external radiotherapy. In surgical<br />
procedure, surgeon removes affected tissue from the neck. Iodine therapy is given to the<br />
patient post operatively to destroy normal thyroid remnants. External radiotherapy is<br />
indicated for the patients with age group 45 years <strong>and</strong> above.<br />
Request for sample report: http://www.futuremarketinsights.com/reports/sample/repgb-1659<br />
The growth of thyroid tumor cells are controlled by thyrotropin <strong>and</strong> is inhibited by<br />
thyroxin, inhibition of thyrotropin with thyroxin increase the recurrence of survival rates.
Report Description<br />
The most commonly used drugs in the treatment of papillary thyroid cancer are<br />
levothyroxine <strong>and</strong> radioiodine <strong>and</strong> antineoplastic agents such as cisplatin, doxorubicin<br />
<strong>and</strong> these drugs are used after the surgery <strong>and</strong> radiation therapy.<br />
<strong>Papillary</strong> <strong>Thyroid</strong> <strong>Cancer</strong> <strong>Market</strong> has been classified on the basis of treatment <strong>and</strong> end<br />
user.<br />
<strong>Papillary</strong> <strong>Thyroid</strong> <strong>Cancer</strong> by Treatment<br />
Surgery<br />
Iodine Therapy<br />
Thyroxin Treatment<br />
External Radiotherapy<br />
Chemotherapy<br />
Cisplatin<br />
Doxorubicin<br />
Drugs<br />
Levothyroxine<br />
Radioiodine
Report Description<br />
<strong>Papillary</strong> <strong>Thyroid</strong> <strong>Cancer</strong> by End User<br />
Hospital<br />
Oncology Centres<br />
Hospital Pharmacies<br />
Retail Pharmacies<br />
In 2015, According to American <strong>Cancer</strong> Society (ACS), thyroid cancer accounts 47,230 in<br />
women <strong>and</strong> 15,220 in men in the U.S. <strong>and</strong> the incidence rate <strong>and</strong> mortality rate of thyroid<br />
cancer is high in women than in men. Thus, the increasing prevalence <strong>and</strong> incidence rate<br />
of thyroid cancers is expected to drive the overall papillary thyroid cancer. Increasing<br />
awareness about the cancer disease, raising government funds <strong>and</strong> reimbursement<br />
policies from Medicare <strong>and</strong> Medicaid are the key factors which are expected to propel<br />
the overall papillary thyroid cancer treatment market. The cost of the drugs <strong>and</strong><br />
procedures is one of the major restraint for papillary thyroid cancer treatment market.<br />
Request for TOC: http://www.futuremarketinsights.com/toc/rep-gb-1659<br />
Depending on geographic region, papillary thyroid cancer market is segmented into<br />
seven key regions: North America, Latin America, Europe, Asia Pacific, <strong>and</strong> Middle East &<br />
Africa. North America is estimated to contribute maximum revenue share in the global<br />
market of <strong>Papillary</strong> <strong>Thyroid</strong> <strong>Cancer</strong> followed by Europe. Asia Pacific regions is expected to<br />
grow at a higher growth rate owing to high occurrence of cancer diseases. Middle East &<br />
Africa is expected to show a healthy growth rate in the forecast period
Report Description<br />
Key players of papillary thyroid cancer market are Mylan pharmaceuticals Inc., Baxter<br />
International Inc., Alara Pharmaceutical Corporation, Abbott laboratories, Bristol Myers<br />
co., Teva parenteral medicines Inc., Jerome Stevens Pharmaceuticals Inc., <strong>and</strong> App<br />
pharmaceuticals llc.
Thank You!<br />
To know more about us, please visit our website:<br />
www.futuremarketinsights.com<br />
For sales queries or new topics email us on:<br />
sales@futuremarketinsights.com<br />
Future <strong>Market</strong> Insights: 616 Corporate Way, Suite 2-9018,<br />
Valley Cottage, NY 10989, United States<br />
T: +1-347-918-3531 | D: +1-845-579-5705